“…Hybrid and EAS are names derived by the manufacturer, Cochlear and MED-EL, respectively. Individuals using these multiple hearing modalities compared with use of a CI alone may demonstrate measurable improvements in speech perception both in quiet and in noise (Ching, Incerti, & Hill, 2004;Ching, van Wanrooy, & Dillon, 2007;Dettman et al, 2004;Firszt, Reeder, & Skinner, 2008;Flynn & Schmidtke, 2004;Gantz & Turner, 2003;Gstoettner et al, 2004;Most, Gaon-Sivan, Shpak, & Luntz, 2012;Mowry et al, 2012;Potts, Skinner, Litovsky, Strube, & Kuk, 2009;Straatman, Rietveld, Beijen, Mylanus, & Mens, 2010;Tuner et al, 2008a;Turner, Reiss, & Gantz, 2008b), sound localization (Ching et al, 2004(Ching et al, , 2007Firszt, et al, 2008;Flynn & Schmidtke, 2004;Potts et al, 2009), music perception (Bartov & Most, 2014;Flynn & Schmidtke, 2004;Mowry et al, 2012;Turner et al, 2008b), and voice recognition (Flynn & Schmidtke, 2004), as well as subjective benefits of access to binaural hearing and sound quality from combined acoustic and electric hearing (Ching et al, 2004;Firszt et al, 2008;Flynn & Schmidtke, 2004;Potts et al, 2009). However, the benefit of the addition of amplification to CI use is variable across individuals, particularly for speech perception, and an effective clinical protocol for programming of multiple hearing modalities has not yet been determined, as not every parameter has been investigated (Blamey & Saunders, 2008;Dorman, Spahr, Loizou, Dana, & Schmidt, 2005;Heo, Lee, & Lee, 2013;…”